Dawnrays Pharmaceutical (Holdings) Limited (2348.HK) HKSE

1.21

+0(+0.00%)

Updated at February 20 02:14PM

Currency In HKD

Valuation

Market Cap1.73B
Enterprise Value601.73M
P/E Ratio9.11
PEG Ratio-0.13
Price/Sales Ratio1.44
Price/Book Ratio0.49
Enterprise/Revenue0.43
Enterprise/EBITDA2.11

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.16
Operating Margin0.15

Management Effectiveness

Return On Assets0.05
Return On Equity0.05

Income Statement

Revenue1.06B
Revenue/Share0.74
Gross Profit577.63M
EBITDA280.49M
Net Income564.94M
Diluted EPS0.38

Balance Sheet

Total Cash1.62B
Total Cash/Share0.9
Total Debt9.16M
Total Debt/Equity0
Current Ratio4.78
Book Value Per Share2.2

Price History

52-Week Change0.83
52-Week High1.47
52-Week Low1.07
Moving Average 50 Days1.2
Moving Average 200 Days1.23

Statistics

Average Volume219,631
Shares Outstanding1.5B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.06
Trailing Annual Dividend Yield5.21
Payout Ratio0.75
Last Split Factor2:1
Last Split DateAugust 06, 2018